QMCO: Nasdaq cites late Quarterly Report; company files Form 12b-25
Rhea-AI Filing Summary
Quantum Corporation disclosed that on August 21, 2025 it received a notice from the Nasdaq Listing Qualifications staff stating the company is not in compliance with Nasdaq Listing Rule 5250(c)(1) because it did not timely file its Quarterly Report for the fiscal quarter ended June 30, 2025. The company previously filed a Form 12b-25 on August 15, 2025 saying the delay stems from additional time needed to finalize financial statements and for its independent auditors to complete their review, including annual and quarterly periods in the Annual Report for the year ended March 31, 2025. Quantum says it is working to complete the review and file the Quarterly Report within Nasdaq's prescribed timeline. The Nasdaq notice does not have an immediate effect on the listing; the stock will continue to trade while the company addresses the filing requirement.
Positive
- Trading continues on Nasdaq despite the notice, so market access remains intact
- Company filed Form 12b-25 and communicated the delay, indicating ongoing engagement with auditors
Negative
- Noncompliance with Nasdaq Listing Rule 5250(c)(1) due to a late Quarterly Report for the period ended June 30, 2025
- Delay involves audited financial statements and independent auditor review, which can indicate complex accounting issues or extended audit procedures
Insights
Late 10-Q triggers Nasdaq notice but trading continues while remediation proceeds.
The company received a compliance notice under Nasdaq Rule 5250(c)(1) for failing to file the Quarterly Report for the period ended June 30, 2025. Quantum filed Form 12b-25 on August 15, 2025 citing additional time needed for finalizing audited financial statements and the external review.
Key dependencies are the completion of the independent registered public accounting firm's review and the timing of the filing; failure to cure within Nasdaq's timeline could lead to further delisting procedures. Monitor the company's subsequent filings and any Nasdaq correspondence within the typical cure period.
Disclosure is a short-term operational/compliance issue that may affect investor confidence.
The notice is procedural: Nasdaq confirmed noncompliance but did not suspend trading, so liquidity and market access remain intact for now. The company issued a press release on August 26, 2025 announcing receipt of the notice and incorporated that release by exhibit.
Investors should watch for the filed Quarterly Report and any auditor communications over the next few weeks; timely filing will resolve the immediate compliance concern.
